English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Press release submission
| Apr 26, 2018
CLEVELAND CLINIC: Study says Genetics May Be to Blame for Child’s Picky Eating
Press release submission
| Apr 26, 2018
UNIVERSITY OF CALIFORNIA SAN FRANCISCO: Giacomini named 2018 Volwiler Research Award recipient
Press release submission
| Apr 26, 2018
AMERICAN CANCER SOCIETY - CINCINNATI: Researchers Report Advances in Lung Cancer Immunotherapy
Press release submission
| Apr 26, 2018
UNIVERSITY OF CALIFORNIA SAN FRANCISCO: Gene Mapping Lays Groundwork for Precision Chemotherapy
Press release submission
| Apr 26, 2018
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK: CDC Launches New Round of Powerful Tobacco Cessation Ads
Press release submission
| Apr 25, 2018
CLEVELAND CLINIC: Children with Autism Less Likely to Get Critical Vaccines
Press release submission
| Apr 25, 2018
UNIVERSITY OF CALIFORNIA SAN FRANCISCO: Football Scuffles, Auto Injuries May Raise Risk for Parkinson’s
Press release submission
| Apr 25, 2018
ELI LILY AND COMPANY: AAN 2018: Lilly's Galcanezumab Significantly Reduced Monthly Migraine Headache Days in Patients with Migraine Who Previously Failed to Respond to Multiple Preventive Therapies
Trending
+
Pharmaceuticals
Patient Daily
| Jun 30, 2025
PhRMA public affairs senior director on 340B program: 'PBMs took $140 billion in rebates and fees, driving up American medicine costs'
+
Pharmaceuticals
Patient Daily
| Jun 23, 2025
PhRMA says patients in the U.S. face higher prescription costs due to 340B program
+
Pharmaceuticals
Patient Daily
| Jun 25, 2025
Neurosurgeon at the University of California: ‘340B is being exploited for profit, not patient care’
« First
«
…
7
8
9
10
11
12
13
…
»
Last »